Question explored with the scientific record
are covid jabs safe and effective
The short version: the mortality data on COVID-19 vaccines is genuinely contradictory, and the honest answer is that "safe and effective" is an assertion, not a proven fact.
The strongest studies here point in opposite directions. A Norwegian cohort of 4.6 million adults found fully vaccinated people died at roughly 40% of the unvaccinated rate across every age band [4]. A Hungarian nationwide cohort found all six vaccines cut all-cause mortality by 49% to 75% after adjusting for the healthy-vaccinee effect [5]. But a UK analysis of the same national data found vaccinated people had higher all-cause death risk than unvaccinated in almost every month, with the gap widening over time [3]. A US county study of 320 million people found more vaccine uptake tracked with more excess mortality in 2022 and 2023 [2]. An Australian reanalysis showed a claimed 51% mortality benefit would require the unvaccinated to have had 121% excess death, which no OECD country approached [1].
| Finding | What it shows |
|---|---|
| Norway, 4.6M adults [4] | Vaccinated died at ~40% of unvaccinated rate |
| Hungary, 6.4M adults [5] | 49-75% mortality reduction, all six vaccines |
| UK ONS data [3] | Vaccinated had higher all-cause death risk over time |
| US counties, 320M [2] | More uptake, more excess mortality 2022-23 |
| Australia reanalysis [1] | Claimed benefit implies implausible 121% unvaccinated excess |
The safety side is real but narrow. Myocarditis after mRNA shots clusters in young males after the second dose, roughly 50 to 139 cases per million in boys 12 to 17 [6]. Most recover, but over half of a small followed group still had heart abnormalities at three months [6]. That is a genuine harm concentrated in a low-risk population. The retrieval did not surface a long-term safety study, and passive reporting systems like VAERS detect almost nothing by design.
My call: the mortality evidence is genuinely split and the observational designs cannot settle it, so "safe and effective" is unproven as a blanket claim. For older adults the benefit signal is stronger; for healthy young people, especially males, the myocarditis risk is real and the mortality benefit is unestablished. Confidence: low, because the studies conflict and none is a clean randomized trial with hard endpoints.
Sources used 6
-
The Claim That COVID-19 Vaccination Protected Australians from All-Cause Mortality Is Not Plausible
Liu et al.'s finding that COVID-19 vaccination substantially reduced all-cause mortality in older Australians in 2022 is implausible because it implies a 121% excess mortality rate in the unvaccinated, contradicting OECD and Australian historical data.
DOI: 10.71189/jim/2026/v02n03a11 -
Why COVID-19 vaccination cannot be ruled out as an explanation for all-cause excess mortality in the pandemic’s aftermath: A population-level study of over 3,000 US counties with over 320 million people
A US county-level study found positive associations between per-capita COVID-19 vaccine uptake and all-cause excess mortality in 2022 and 2023, even when adjusting for lagged mortality, but the design cannot establish causation.
DOI: 10.12688/f1000research.177279.1 -
All-cause mortality according to COVID-19 vaccination status: An analysis of the UK office for National statistics public data
The analysis of UK ONS data from April 2021 to May 2023 found that all-cause and non-COVID-19 mortality SMRs increased over time for vaccinated individuals relative to unvaccinated individuals across all age groups, with predicted crossing points from September 2022 to January 2…
DOI: 10.12688/f1000research.154058.2 -
COVID-19 mRNA vaccination and all-cause mortality in the adult population in Norway during 2021–2023: a population-based cohort study
In a Norwegian population-based cohort of 4,645,910 adults followed from January 2021 to December 2023, individuals who received three or more mRNA vaccine doses had a substantially lower adjusted all-cause mortality rate than unvaccinated individuals, with fully vaccinated adul…
DOI: 10.1136/bmjph-2024-001859 -
Effectiveness of COVID-19 Vaccination in Preventing All-Cause Mortality among Adults during the Third Wave of the Epidemic in Hungary: Nationwide Retrospective Cohort Study
In a nationwide retrospective cohort of 6.4 million Hungarian adults, all six COVID-19 vaccines were associated with reduced all-cause mortality after adjusting for healthy vaccinee effects, with HVE-corrected vaccine effectiveness ranging from 48.7% for Pfizer-BioNTech to 75.4%…
DOI: 10.3390/vaccines10071009 -
Incidence, risk factors, natural history, and hypothesised mechanisms of myocarditis and pericarditis following covid-19 vaccination: living evidence syntheses and review
This living systematic review found that myocarditis after mRNA COVID-19 vaccination occurs most frequently in male adolescents and young adults, with moderate-certainty evidence that Moderna is associated with higher incidence than Pfizer in 18-29 year olds and low-certainty ev…
DOI: 10.1136/bmj-2021-069445